59
Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities Grid The AAP CME/CPD program develops, maintains, and improves the competence, skills, and professional performance of pediatricians and pediatric healthcare professionals by providing quality, relevant, accessible, and effective educational experiences that address gaps in professional practice. The AAP CME/CPD program strives to meet the educational needs of pediatricians and pediatric healthcare professionals and support their lifelong learning with a goal of improving care for children and families. (AAP CME/CPD Program Mission Statement, May 2015) The AAP recognizes that there are a variety of financial relationships between individuals and commercial interests that require review to identify possible conflicts of interest in a CME activity. The “AAP Policy on Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities” is designed to ensure quality, objective, balanced, and scientifically rigorous AAP CME activities by identifying and resolving all potential conflicts of interest prior to the confirmation of service of those in a position to influence and/or control CME content. The AAP has taken steps to resolve any potential conflicts of interest. All AAP CME activities will strictly adhere to the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support: Standards to Ensure the Independence of CME Activities. In accordance with these Standards, the following decisions will be made free of the control of a commercial interest: identification of CME needs, determination of educational objectives, selection and presentation of content, selection of all persons and organizations that will be in a position to control the content, selection of educational methods, and evaluation of the CME activity. The purpose of this policy is to ensure all potential conflicts of interest are identified and mechanisms to resolve them prior to the CME activity are implemented in ways that are consistent with the public good. The AAP is committed to providing learners with commercially unbiased CME activities. Activity Title: 2019 National Conference & Exhibition Activity Location: New Orleans, LA Activity Dates: 10/25/2019 – 10/29/2019 DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Name Role Relevant Financial Relationship (Please indicate Yes or No) Name of Commercial Interest(s)* Please list name(s) of entity AND Nature of Relevant Financial Relationship(s) (Please list: Research Grant, Speaker’s Bureau, Stock/Bonds excluding mutual funds, Consultant, Other - identify) Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an unapproved or “off-label” use of an approved device or pharmaceutical. (Do intend to discuss or Do not intend to discuss) Abrams, Steven Faculty Yes Milk Processors Educational Program: Paid Consultant I do not intend to discuss Abzug, Joshua Faculty, Moderator Yes Springer: Royalties I do not intend to discuss Agarwal, Rita Faculty No None I do intend to discuss Agus, Michael Faculty No None I do intend to discuss Ajayi, Akinyemi Faculty Yes Jazz Pharmaceuticals: Paid Consultant; Speakers' Bureau I do not intend to discuss

Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities Grid The AAP CME/CPD program develops, maintains, and improves the competence, skills, and professional performance of pediatricians and pediatric healthcare professionals by providing quality, relevant, accessible, and effective educational experiences that address gaps in professional practice. The AAP CME/CPD program strives to meet the educational needs of pediatricians and pediatric healthcare professionals and support their lifelong learning with a goal of improving care for children and families. (AAP CME/CPD Program Mission Statement, May 2015)

The AAP recognizes that there are a variety of financial relationships between individuals and commercial interests that require review to identify possible conflicts of interest in a CME activity. The “AAP Policy on Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities” is designed to ensure quality, objective, balanced, and scientifically rigorous AAP CME activities by identifying and resolving all potential conflicts of interest prior to the confirmation of service of those in a position to influence and/or control CME content. The AAP has taken steps to resolve any potential conflicts of interest.

All AAP CME activities will strictly adhere to the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support: Standards to Ensure the Independence of CME Activities. In accordance with these Standards, the following decisions will be made free of the control of a commercial interest: identification of CME needs, determination of educational objectives, selection and presentation of content, selection of all persons and organizations that will be in a position to control the content, selection of educational methods, and evaluation of the CME activity.

The purpose of this policy is to ensure all potential conflicts of interest are identified and mechanisms to resolve them prior to the CME activity are implemented in ways that are consistent with the public good. The AAP is committed to providing learners with commercially unbiased CME activities.

Activity Title: 2019 National Conference & Exhibition Activity Location: New Orleans, LA Activity Dates: 10/25/2019 – 10/29/2019

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Abrams, Steven Faculty Yes Milk Processors Educational Program: Paid Consultant

I do not intend to discuss

Abzug, Joshua Faculty, Moderator

Yes Springer: Royalties I do not intend to discuss

Agarwal, Rita Faculty No None I do intend to discuss

Agus, Michael Faculty No None I do intend to discuss

Ajayi, Akinyemi Faculty Yes Jazz Pharmaceuticals: Paid Consultant; Speakers' Bureau

I do not intend to discuss

Page 2: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Albanese, Stephen Faculty No None I do intend to discuss

Alverson, Dale Faculty Yes Welcome Home Health: Paid Consultant GlobalMed: Paid Consultant Vision Quest: Paid Consultant

I do not intend to discuss

Balistreri, William Faculty Yes Gilead Sciences: Research Grant Merck: Research Grant AbbVie: Research Grant Alexion Pharma GmbH: Scientific Advisory Board Digestive Care: Consultant Kadmon Pharmaceuticals, LLC: Advisory Board Otsuka: Consultant

I do not intend to discuss

Barnert, Elizabeth Faculty No None I do intend to discuss

Barnett, Elizabeth Faculty Yes PaxVax: Research Grant Wolters Kluwer: Royalties AAP: Royalties BMJ Best Practice: Honorarium

I do intend to discuss

Berman, Suzanne Faculty, Moderator

Yes Connexin Software: Paid Consultant Script Doctor LLC: Employee

I do not intend to discuss

Betancourt, Theresa Faculty No None I do intend to discuss

Biondi, Eric AAP Section/Council Abstract Chair

Yes McKesson Inc: Paid Consultant I do not intend to discuss

Bree, Alanna Faculty No None I do intend to discuss

Breuner, Cora Faculty No None I do intend to discuss

Page 3: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Brooks, Lee AAP Section/Council Program Chair

Yes Merrill Lynch: Stocks/Bonds Abbvie: Stocks/Bonds Saepta: Stocks/Bonds Cardinal Health: Stocks/Bonds LabCorp: Stocks/Bonds Novartis: Stocks/Bonds CVS: Stocks/Bonds Teva: Stocks/Bonds Pfizer: Stocks/Bonds Roche: Stocks/Bonds GlaxoSmith Kline (GSK): Stocks/Bonds Sanofi: Stocks/Bonds Merck: Stocks/Bonds Johnson & Johnson: Stocks/Bonds Bristol Myers: Stocks/Bonds Henry Schein: Stocks/Bonds Bausch Health: Stocks/Bonds Coca-Cola: Stocks/Bonds Pepsi Co.: Stocks/Bonds

I do not intend to discuss

Brothers, Kyle Moderator No None I do intend to discuss

Bucci-Rechtweg, Christina

AAP Section/Council Program Chair

Yes Novartis Pharmaceuticals Corporation: Employee; Shareholder

I do not intend to discuss

Bulas, Dorothy Faculty No None I do intend to discuss

Burstein, Gale Planning Group Member

Yes Allergan Pharma: Speakers' Bureau - Spouse/Partner I do not intend to discuss

Cain, Kathleen Faculty Yes Main Street Vaccines: Employee I do not intend to discuss

Page 4: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Campbell, James Faculty Yes Merck: Research Grant Sanofi: Research Grant GSK: Research Grant Sanaria: Data Safety Monitoring Board

I do intend to discuss

Chaffee, Tonya Faculty Yes Merck Inc: Trainer Hologic: Paid Consultant

I do not intend to discuss

Chan, Yee-Ming Faculty Yes Endo Pharmaceuticals: Paid Consultant I do intend to discuss

Chang, Todd Faculty Yes SBC Med Sim, LLC: Independent Contractor Oculus from FaceBook: Research Grant

I do not intend to discuss

Corcoran, Julia Faculty Yes Immersive Touch, Inc: Stocks/Bonds I do not intend to discuss

Cosgrove, Lisa Moderator Yes Teladoc: Stocks/Bonds Spouse I do not intend to discuss

Dahl-Grove, Deanna Faculty No None I do intend to discuss

Danielpour, Lisa Faculty Yes Allscripts: Honorarium I do not intend to discuss

de Souza, Luciara Faculty Yes Cerner Corporation: Employee I do not intend to discuss

Devarajan, Prasad Faculty Yes BioPorto Inc: Licensing Agreement on Patents I do not intend to discuss

Di Lorenzo, Carlo Faculty Yes Mahana: Paid Consultant QOL: Paid Consultant Shire: Paid Consultant Allergan: Paid Consultant

I do intend to discuss

Dietert, Rodney Faculty Yes Seed: Paid Consultant I do not intend to discuss

Eneli, Ihuoma Faculty Yes Rhythm Pharmaceuticals: Research Grant I do intend to discuss

Page 5: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Espinosa, Claudia AAP Section/Council Program Chair

Yes AstraZeneca: Speakers' Bureau Gilead: Research Grant Nabriva: Research Grant Durata Therapeutic: Research Grant Allergan: Research Grant The Medicine Company: Research Grant Merck: Research Grant PRA Health Sciences: Reserach Grant

I do not intend to discuss

Fanaroff, Jonathan Faculty Yes Monogram Orthopaedics, Inc.: Investor I do not intend to discuss

Fisher, Margaret Faculty No None I do intend to discuss

Fleegler, Eric Faculty Yes Veta Health: Paid Consultant Wolters Kluwer: Royalties Springer Nature: Editor Fee

I do not intend to discuss

Flynn, Joseph Faculty Yes Silvergate Pharmaceuticals: Paid Consultant Ultragenyx, Inc: Data and Safety Monitoring Board Springer: Royalties Wolters Kluwer: Royalties NIDDK: Research Grant American Heart Association: Research Grant

I do not intend to discuss

Fogel, Mark Moderator No None I do intend to discuss

Forkey, Heather Faculty No Precision Optics Corporation: Employee (Spouse) I do not intend to discuss

Foulds, Michael Planning Group Member

No None I do intend to discuss

Freed, Michael Faculty No None I do intend to discuss

Page 6: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Frenck, Robert AAP Section/Council Program Chair

Yes Merck: Research Grant Pfizer: Research Grant GSK: Research Grant

I do not intend to discuss

Gargiulo, Dominic Teaching Assistant

No None I do intend to discuss

Gerardin, Jennifer AAP Section/Council Abstract Chair

No None I do intend to discuss

Ghali, Fred Faculty Yes Galderma Labs, USA: Speakers' Bureau Ortho Dermatologics: Speakers' Bureau Proctor & Gamble: Honorarium Advisory Board Pierre-Fabre: Speakers' Bureau Promius Pharmaceuticals: Speakers' Bureau Sanofi-Regeneron: Speakers' Bureau Verrica Pharmaceuticals: Honorarium Advisory Board Leo Pharmaceuticals: Research Grant Top MD, Inc.: Stocks/Bonds Pfizer: Honorarium Cutanea Pharmaceuticals: Honorarium

I do intend to discuss

Gillette, Meredith Faculty Yes Novo Nordisk: Paid Consultant I do not intend to discuss

Gleason, Mary Margaret Faculty Yes William Josef Foundation, Institute of Mental Hygiene: Program Funding

I do not intend to discuss

Green, Andrea Faculty No None I do intend to discuss

Greenberg, Katherine Faculty Yes Merck: Speakers' Bureau I do intend to discuss

Griffiths, Anne Faculty Yes Vertex Pharmaceuticals, INC: Research Grant Parion Sciences, INC: Research Grant

I do intend to discuss

Page 7: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Hamele, Mitchell Faculty Yes US, Department of Defense: Employee I do not intend to discuss

Hart, Chip Faculty Yes PCC: Employee PedsOne: Minority Owner

I do not intend to discuss

Hassink, Sandra Planning Group Member

Yes Weight Watchers: Honorarium I do not intend to discuss

Hays, Stephen Faculty No None I do intend to discuss

Hiramatsu, Mika Planning Group Member

Yes Abbott Labs: Stocks/Bonds Agilent Tech: Stocks/Bonds Baxter Intl: Stocks/Bonds Brooks Automation: Stocks/Bonds Entegris Inc: Stocks/Bonds Royal Philips Electronics Co LTD: Stocks/Bonds Kyocera Corp: Stocks/Bonds Panasonic Corp: Stocks/Bonds Shire PLC: Stocks/Bonds RTI Surgical Inc: Stocks/Bonds Varian Medical Systems, Inc.: Stocks/Bonds Varex Imaging Corporation: Stocks/Bonds

I do not intend to discuss

Hogan, Angela Faculty Yes GSK: Speakers' Bureau I do not intend to discuss

Hornik, Christoph Faculty No None I do intend to discuss

Hubbard, Dena Faculty, Moderator

Yes Abbott Nutrition: Speakers' Bureau I do not intend to discuss

Hunt, Reagan Faculty Yes Wolters Kluwer: Royalties Medscape, LLC: Royalties Dermavant: Paid Consultant

I do intend to discuss

Page 8: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Inge, Thomas Faculty Yes Standard Bariatrics: Honorarium Wolters Kluwer: Honorarium Independent Medical Expert Consulting Services: Honorarium

I do not intend to discuss

Kadom, Nadja Faculty No None I do intend to discuss

Kang, Peter Faculty Yes AveXis: Paid Consultant ChromaDex: Paid Consultant Sarepta Therapeutics: Paid Consultant Springer: Co-editor Wiley: Associate Editor Wolters Kluwer: Author

I do intend to discuss

Kaye, David Faculty Yes Pfizer: Clinical Trial Health Now/BlueCross BlueShield: QI Committee

I do not intend to discuss

Keeshin, Brooks Faculty Yes Wolters Kluwer: Royalties Hunter College: Paid Consultant SAMHSA: Research Grant Uppsala University: Research Grant

I do not intend to discuss

Kim, Jae Faculty Yes Medela: Paid Consultant Mead Johnson: Speakers' Bureau Abbott Nutrition: Speakers' Bureau Ferring: Paid Consultant Mallinckrodt: Research Grant Pediasolutions: Stocks/Bonds Nicolette: Stocks/Bonds Astarte: Stocks/Bonds Evolve: Paid Consultant Alcresta: Paid Consultant Astarte: Paid Consultant

I do not intend to discuss

Kimberlin, David Faculty Yes Novavax: Research Grant I do intend to discuss

Page 9: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Kirkendall, Eric AAP Section/Council Abstract Chair

Yes Vigilanxz: Royalties I do not intend to discuss

Kressly, Susan Faculty Yes Connexin Software: Employee (Self & Spouse/Partner) Pediatric Management Institute: Paid Consultant AccuVax: Paid Consultant

I do not intend to discuss

Krugman, Scott AAP Section/Council Program Chair

No None I do intend to discuss

Kundu, Anjana Faculty No None I do intend to discuss

Kuriakose, Kevin Faculty No None I do intend to discuss

Lam, Wilbur Moderator Yes Sanguina LLC: Stocks/Bonds I do intend to discuss

Lee, Lois Faculty Yes Wolters Kluwer: Royalties I do not intend to discuss

Logan, Kelsey Faculty, AAP Section/Council Program Chair

No None I do intend to discuss

Long, Justin Faculty No None I do intend to discuss

Madden, Susanne Faculty Yes Verden Group: Shareholder Patient Centered Solutions: Shareholder National Breastfeeding Center: Shareholder Independent Practice MSO: Shareholder

I do not intend to discuss

Mahle, William Faculty No None I do intend to discuss

Page 10: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Maisels, Jeffrey Faculty Yes Draeger Medical: Paid Consultant Capnia: Paid Consultant

I do not intend to discuss

Majumdar, Indrajit Faculty Yes Rhythm Pharmaceuticals: Clinical Trial Novo Nordisk: Clinical Trial OPKO Health: Clinical Trial Pfizer: Clinical Trial

I do not intend to discuss

Mauch, Teri Faculty Yes Alexion Pharmaceuticals: Research Grant I do not intend to discuss

McColley, Susanna Faculty, AAP Section/Council Program Chair

Yes Vertex Pharmaceuticals, Inc: Paid Consultant; Speakers' Bureau

I do not intend to discuss

Mears, Cynthia Faculty Yes Pfizer: Speakers' Bureau I do not intend to discuss

Melwani, Anjna Faculty No None I do intend to discuss

Messacar, Kevin Faculty Yes National Institute of Allergy and Infectious Diseases: Research Grant

I do intend to discuss

Minich, L. LuAnn Moderator No None I do intend to discuss

Mistovich, Ronald Moderator Yes Orthopediatrics: Paid Consultant Right Mechanics: Stocks/Bonds

I do not intend to discuss

Nataro, James Faculty Yes Innovate: Paid Consultant I do not intend to discuss

Neu, Josef Faculty Yes Infant Bacterial Therapeutics: Research Grant I do not intend to discuss

Newland, Jason Faculty Yes Merck: Research Grant Allergan: Clinical Trial

I do not intend to discuss

Ngo, Thuy AAP Section/Council Program Chair

Yes Welch Allyn: Paid Consultant I do not intend to discuss

Page 11: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Nurko, Samuel Faculty Yes Allergan inc: Research Grant Sucampo Pharmaceutica: Honorarium (Consultant)

I do not intend to discuss

Oakley, Christopher Faculty No None I do intend to discuss

O'Connor, Mary Faculty No None I do intend to discuss

Otsuka, Norman Faculty Yes Journal of the American Academy of Orthopaedic Surgeons: Paid Consultant

I do not intend to discuss

Palmer, Blake Faculty Yes Astellas: Research Grant I do not intend to discuss

Parker, Margaret AAP Section/Council Program Chair

No None I do intend to discuss

Parnes, Mered Faculty Yes Kadmon Corporation: Honorarium PTC Therapeutics: Honorarium Teva Pharmaceutical Industries Ltd: Paid Consultant Medlink: Royalties

I do intend to discuss

Parsi, Linda Faculty Yes Parsi Pediatrics: Owner The P.E.D.S. MD Company: Owner

I do not intend to discuss

Parsons, Julie Faculty Yes Biogen: Research Grant; Honorarium AveXis: Research Grant; Honorarium Scholar Rock: Research Grant PTC Therapeutics: Research Grant

I do intend to discuss

Partap, Sonia Faculty No None I do intend to discuss

Pasternak, Ryan Faculty No None I do intend to discuss

Patel, Aloka Faculty Yes Mead Johnson Nutrition: Research Grant I do not intend to discuss

Page 12: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Peltier, Christopher Faculty, Moderator

Yes Mead Johnson: Speakers' Bureau Merck: Research Grant GSK: Research Grant Sanofi: Research Grant BBN Nutrition: Research Grant

I do not intend to discuss

Petersen, Brett Faculty No None I do intend to discuss

Pitt, Michael Faculty No None I do intend to discuss

Prudent, Joshua AAP Section/Council Abstract Chair

No None I do intend to discuss

Puttgen, Katherine Faculty No None I do intend to discuss

Radesky, Jenny Faculty Yes Public Broadcasting Service: Paid Writer Melissa & Doug Toys: Paid Consultant

I do not intend to discuss

Rager, Kristin Faculty No None I do intend to discuss

Reber, Kristina Moderator Yes Procter and Gamble: Stocks/Bonds (Spouse) Children's Hospital Neonatal Consortium: Executive Board

I do not intend to discuss

Reynolds, Jason Faculty No None I do intend to discuss

Riccio, Anthony Faculty Yes Elsevier: Royalties I do not intend to discuss

Rios, Angel AAP Section/Council Program Chair

No None I do intend to discuss

Ross, Lainie Faculty Yes GE: Stocks/Bonds Bristol Meyers Squibb: Stocks/Bonds

I do not intend to discuss

Page 13: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Rouce, Rayne Faculty Yes Novartis Pharmaceuticals: Honorarium KITE/Gilead Pharma: Honorarium TESSA Pharmaceuticals: Research Grant

I do intend to discuss

Rowe, Peter Faculty No None I do intend to discuss

Rowley, Anne Heitzman Planning Group Member

Yes Wolters Kluwer: Paid Consultant I do not intend to discuss

Rush, Eric Faculty Yes Alexion Pharmaceuticals: Speakers' Bureau Ultragenyx Pharmaceuticals: Speakers' Bureau Biomarin Pharmaceuticals: Paid Consultant Abeona Therapeutics: Stocks/Bonds Affimed NV: Stocks/Bonds Amarin Corp PC: Stocks/Bonds Array Biopharma: Stocks/Bonds Aveo Pharmaceuticals: Stocks/Bonds Bristol Meyers Squibb: Stocks/Bonds Celgene Inc: Stocks/Bonds Clovis Oncology: Stocks/Bonds Deciphera Pharmaceuticals: Stocks/Bonds Genmab AS: Stocks/Bonds Halozyme Therapeutics: Stocks/Bonds Intercept Pharmaceuticals: Stocks/Bonds Kala Pharmaceuticals: Stocks/Bonds Portola Pharmaceuticals: Stocks/Bonds Scynexis Inc: Stocks/Bonds Seattle Genetics: Stocks/Bonds Spectrum Pharmaceuticals: Stocks/Bonds Trillium Therapeutics: Stocks/Bonds VolitionRx: Stocks/Bonds

I do not intend to discuss

Sandel, Megan Faculty Yes Enterprise Community Partners: Board of Trustees I do not intend to discuss

Page 14: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Schechter, Michael Faculty Yes Abbvie: Paid Consultant; Speakers' Bureau Novartis: Research Grant Translate Bio: Research Grant

I do not intend to discuss

Scherl, Susan Faculty Yes Wolters Kluwer: Royalties Lippincott/Wolters Kluwer: Royalties

I do not intend to discuss

Scholer, Seth Faculty Yes Play Nicely Program: Royalties I do not intend to discuss

Schonwald, Alison Faculty No None I do intend to discuss

Sectish, Theodore Faculty Yes I-PASS Patient Safety Institute: Paid Consultant (Spouse)

I do not intend to discuss

Shah, Binita Faculty Yes McGraw-Hill Co: Royalties, Research Grant Symposia Medicus: Honorarium

I do not intend to discuss

Shelov, Eric AAP Section/Council Program Chair

No None I do intend to discuss

Shu, Jennifer Planning Group Member

Yes AAP: Royalties I do not intend to discuss

Sicherer, Scott Faculty Yes HAL Allergy: Research Grant I do intend to discuss

Silver, Alyssa Faculty No None I do intend to discuss

Slusher, Tina Faculty No None I do intend to discuss

Smith, P. Brian AAP Section/Council Program Chair

No None I do intend to discuss

Page 15: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Sohl, Kristin Faculty Yes Autism Navigator/Florida State University: Paid Consultant Autism Speaks: Research Grant HRSA/MCHB: Research Grant Quadrant Biosciences: Honorarium; Research Grant Missouri Department of Mental Health: State Contract University of New Mexico: Paid Consultant

I do not intend to discuss

Song, Clara AAP Section/Council Abstract Chair

Yes Mead Johnson Nutrition: Speakers' Bureau I do not intend to discuss

Spector, Nancy Faculty, Moderator

Yes I-PASS Patient Safety Institute: Founder PCCORI: Research Grant

I do not intend to discuss

Starke, Jeffrey Faculty Yes Otsuka Pharmaceuticals: Data Safety Monitoring Board

I do not intend to discuss

Stricker, Paul Faculty Yes The Juice Plus Company: Paid Health Advisory Board Consultant

I do not intend to discuss

Suchdev, Parminder Faculty No None I do intend to discuss

Suh, Donny Faculty Yes National Institute of Health: Investigator I do not intend to discuss

Sweeney, Brooke Faculty No None I do intend to discuss

Tan, Tina Faculty Yes Sanofi Pasteur: Research Grant Merck: Research Grant Pfizer: Research Grant DMID: Data Safety Monitoring Committee ILiAd Biotechnologies: DMSB

I do not intend to discuss

Tandon, Animesh Moderator Yes Synergen Tech Labs: Research Grant VARYFII Imagining: Stocks/Bonds

I do not intend to discuss

Page 16: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Teitelbaum, Jonathan Planning Group Member

Yes Wolters Kluwer: Royalties I do not intend to discuss

Theos, Amy Faculty No None I do intend to discuss

Thilo, Elizabeth Faculty No None I do intend to discuss

Tridas, Eric Faculty Yes Tris Pharma: Speakers' Bureau; Paid Consultant Shire: Paid Consultant

I do not intend to discuss

Twombley, Katherine Planning Group Member

Yes Novartis: Research Grant Kaneka: Research Grant

I do not intend to discuss

Velez-Yanguas, Maria Faculty Yes NovoNordisk: Paid Consultant Octapharma: Paid Consultant

I do not intend to discuss

Vogel, Tiphanie Faculty No None I do intend to discuss

Wang, Julie AAP Section/Council Program Chair

Yes DBV Technologies: Paid Consultant ALK Abello: Paid Consultant

I do not intend to discuss

Weems, Mark Faculty Yes Abbott: Paid Consultant I do not intend to discuss

Weiner, Gary Faculty No None I do intend to discuss

Wexelblatt, Scott Faculty Yes Abbott Nutrition: Speakers' Bureau I do not intend to discuss

White, Robert Faculty Yes Philips: Paid Consultant Natus: Paid Consultant Mednax: Employee

I do not intend to discuss

Whitehead, Ralph Faculty No None I do intend to discuss

Winter, Jameel Teaching Assistant

No None I do intend to discuss

Page 17: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Witchel, Selma F. Faculty No None I do intend to discuss

Wolraich, Mark Faculty No None I do intend to discuss

Wolynn, Todd Planning Group Member

Yes Merck: Paid Consultant Sanofi: Speakers' Bureau National Breastfeeding Center: Employee Kids Plus Pediatrics: Employee

I do not intend to discuss

Wusthoff, Courtney Faculty Yes Ceribell: Paid Consultant I do not intend to discuss

Yen, Yi-Meng AAP Section/Council Abstract Chair

Yes Smith-Nephew: Paid Consultant Orthopediatrics: Paid Consultant

I do not intend to discuss

Zempsky, William Faculty Yes Glaxo Smith Kline: Paid Consultant Pfizer: Paid Consultant Endo Pharmaceuticals: Data Safety Monitoring Board Vapogenix: Scientific Advisory Board

I do not intend to discuss

Page 18: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities Grid The AAP CME/CPD program develops, maintains, and improves the competence, skills, and professional performance of pediatricians and pediatric healthcare professionals by providing quality, relevant, accessible, and effective educational experiences that address gaps in professional practice. The AAP CME/CPD program strives to meet the educational needs of pediatricians and pediatric healthcare professionals and support their lifelong learning with a goal of improving care for children and families. (AAP CME/CPD Program Mission Statement, May 2015)

The AAP recognizes that there are a variety of financial relationships between individuals and commercial interests that require review to identify possible conflicts of interest in a CME activity. The “AAP Policy on Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities” is designed to ensure quality, objective, balanced, and scientifically rigorous AAP CME activities by identifying and resolving all potential conflicts of interest prior to the confirmation of service of those in a position to influence and/or control CME content. The AAP has taken steps to resolve any potential conflicts of interest.

All AAP CME activities will strictly adhere to the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support: Standards to Ensure the Independence of CME Activities. In accordance with these Standards, the following decisions will be made free of the control of a commercial interest: identification of CME needs, determination of educational objectives, selection and presentation of content, selection of all persons and organizations that will be in a position to control the content, selection of educational methods, and evaluation of the CME activity.

The purpose of this policy is to ensure all potential conflicts of interest are identified and mechanisms to resolve them prior to the CME activity are implemented in ways that are consistent with the public good. The AAP is committed to providing learners with commercially unbiased CME activities.

Activity Title: 2019 National Conference & Exhibition Activity Location: New Orleans, LA Activity Dates: 10/25/2019 – 10/29/2019

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Ackerman, Michael Abstract Reviewer

Yes AliveCor: Royalties Audentes Therapeutics: Consultant Blue Ox Health: Potential royalties Boston Scientific: Consultant Gilead Sciences: Consultant Invitae: Consultant Medtronic: Consultant MyoKardia: Consultant St. Jude Medical: Consultant StemoniX: Royalties

I do not intend to discuss

Page 19: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Afzal, Bushra Co-Author, Senior Author

No None I do intend to discuss

Alfath, Zineb Co-Author No None I do intend to discuss

Anderson, Patricia Senior Author, Co-Author

Yes Bryn Pharma: Consultant I do not intend to discuss

Andras, Lindsay Presenting Author, Co-Author

Yes Biomet: Consultant; Speaker Eli Lilly: Stocks/Bonds Journal of Pediatric Orthopedics: Editorial or Governing Board Medtronic: Consultant; Speaker NuVasive: Consultant; Speaker's Bureau Orthobullets: Publishing Royalties; Financial or Material Support Pediatric Orthopaedic Society of North America: Board/Committee Member Scoliosis Research Society: Board/Committee Member Zimmer: Consultant

I do not intend to discuss

Aouthmany, Moustafa Abstract Reviewer

Yes Abbott Nutrition: Neonatology Advisory I do not intend to discuss

Arkader, Alexandre Senior Author, Co-Author

Yes Clementia: Consultant Orthofix: Consultant; Speaker's Bureau Orthopediatrics: Consultant; Speaker's Bureau

I do not intend to discuss

Armstrong, Sarah Abstract Reviewer

Yes AstraZeneca: Research Grant Rhythm Pharmaceuticals: Speaker's Bureau

I do not intend to discuss

Page 20: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Atanda, Alfred Co-Author, Senior Author

Yes Center for Advanced Orthopedics: Consultant Community E-consult Network: Consultant GW Medical Associates: Consultant XpertCare: Consultant

I do not intend to discuss

Axelrod, David Co-Author Yes Lighthaus Inc: Stocks/Bonds I do not intend to discuss

Babl, Franz E Senior Author No None I do intend to discuss

Bailey, Michael Co-Author Yes Scioto Biosciences: Stocks/Bonds I do not intend to discuss

Bakker, Jill Co-Author No None I do intend to discuss

Banerjee, Ritu Presenting Author, Co-Author

Yes Accelerate Diagnostics: Research Grant BioFire: Research Grant Biomerieux: Research Grant Roche: Research Grant

I do not intend to discuss

Bansal, Ashish Co-Author Yes Regeneron Pharmaceuticals, Inc: Employee; Stocks/Bonds

I do not intend to discuss

Baselga, Eulalia Presenting Author, Senior Author

Yes Pierre Fabre: Consultant I do not intend to discuss

Bass, Alice Co-Author No None I do intend to discuss

Becken, Bradford Presenting Author, Co-Author

No None I do intend to discuss

Beers, Nathaniel Abstract Reviewer

Yes Amazon: Stocks/Bonds Apple: Stocks/Bonds General Mills: Stocks/Bonds IBM: Stocks/Bonds

I do not intend to discuss

Bergonzelli, Gabriela Co-Author Yes Nestle: Employee I do not intend to discuss

Page 21: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Besner, Gail Presenting Author, Co-Author, Senior Author

Yes Scioto Biosciences: Consultant; Research Grant; Stocks/Bonds

I do not intend to discuss

Bhakta, Hemangini Co-Author, Presenting Author

No None I do intend to discuss

Bhatia, Amina Senior Author, Co-Author

No None I do intend to discuss

Biko, David Presenting Author, Co-Author

No None I do intend to discuss

Biondi, Eric Abstract Reviewer

Yes McKesson Inc: Consultant I do not intend to discuss

Page 22: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Blauvelt, Andrew Co-Author Yes Abbvie: Consultant; Research Grant Aclaris: Consultant; Research Grant Allergan: Consultant; Research Grant Almirall: Consultant; Research Grant Amgen: Consultant; Research Grant Boehringer-Ingelheim: Consultant; Research Grant Celgene: Consultant; Research Grant Dermavant: Consultant; Research Grant Dermira: Consultant; Research Grant Eli Lilly: Consultant; Research Grant; Speaker's Bureau Genentech/Roche: Consultant; Research Grant GlaxoSmithKline: Consultant; Research Grant Janssen: Consultant; Research Grant; Speaker's Bureau LEO Pharma: Consultant; Research Grant Merck: Consultant; Research Grant Novartis: Consultant; Research Grant Pfizer: Consultant; Research Grant Purdue Pharma: Consultant; Research Grant Regeneron Pharmaceuticals, Inc: Consultant; Research Grant; Speaker's Bureau Sandoz: Consultant; Research Grant Sanofi Genzyme: Consultant; Research Grant; Speaker's Bureau Sienna Pharmaceuticals: Consultant; Research Grant Sun Pharma: Consultant; Research Grant UCB: Consultant; Research Grant Valeant Pharmaceutical Co: Consultant; Research Grant Vidac: Consultant; Research Grant

I do not intend to discuss

Page 23: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Boguniewicz, Mark Co-Author Yes Eli Lilly: Consultant Regeneron Pharmaceuticals, Inc: Consultant; Research Grant; Speaker's Bureau Sanofi: Consultant; Research Grant; Speaker's Bureau

I do not intend to discuss

Bouchillon, Samuel Co-Author, Presenting Author

Yes International Health Management Associates, Inc: Consultant

I do not intend to discuss

Bresnahan, Brian Co-Author Yes Bill and Melinda Gates Foundation: Research Grant Johnson & Johnson: Stocks/Bonds University of Washington Medical Center and Harborview Medical Center: Employee; Research Grant

I do intend to discuss

Brown, Heather Co-Author Yes Evolve Biosystems: Employee I do not intend to discuss

Brown, Lou Ann Co-Author No None I do intend to discuss

Bucci-Rechtweg, Christina

Abstract Reviewer

Yes Novartis Pharmaceuticals: Employee; Stocks/Bonds I do not intend to discuss

Bui, Kim Chi Co-Author, Presenting Author

No None I do intend to discuss

Busch, Michael Co-Author Yes Arthrex, Inc: Speaker I do not intend to discuss

Calkins, Kara Co-Author, Senior Author

Yes Baxter: Consultant Fresenius Kabi: Consultant

I do intend to discuss

Campbell-Washburn, Adrienne

Co-Author No None I do intend to discuss

Canterberry, Sharon Co-Author No None I do intend to discuss

Page 24: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Caperell, Kerry Co-Author, Presenting Author

No None I do intend to discuss

Capone, Kimberly Presenting Author

Yes Johnson & Johnson Consumer, Inc: Employee I do not intend to discuss

Cartwright, Martina Senior Author, Presenting Author

Yes Abbott Nutrition: Consultant; Speaker's Bureau Blue Diamond Almonds: Consultant Cassiopea Inc: Employee; Stocks/Bonds Cassiopea SpA: Consultant NICO Neuro Inc: Consultant

I do intend to discuss

Casaburi, Giorgio Co-Author, Presenting Author

Yes Evolve Biosystems: Employee I do not intend to discuss

Cauvel, Teresa Co-Author Yes Neopenda PBC: Employee; Stocks/Bonds I do not intend to discuss

Cazeau, Christine Co-Author, Presenting Author

Yes Pierre Fabre: Employee I do not intend to discuss

Chen, Zhen Co-Author Yes Regeneron Pharmaceuticals, Inc: Employee; Stocks/Bonds

I do not intend to discuss

Chew, Stephanie Senior Author, Co-Author

Yes Evolve Biosystems: Employee I do not intend to discuss

Page 25: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Childress, Ann Presenting Author, Co-Author

Yes Aevi Genomic Medicine: Research Grant Akili Interactive Labs: Consultant; Research Grant Alcobra Pharma: Research Grant Arbor Pharmaceuticals, LLC: Consultant; Research Grant; Speaker's Bureau; Writing Support Eli Lilly: Research Grant Forest Laboratories: Research Grant Ironshore Pharmaceuticals & Development, Inc: Consultant; Research Grant; Writing Support KemPharm, Inc: Research Grant Lundbeck: Research Grant Neos Therapeutics: Consultant; Research Grant; Speaker's Bureau; Writing Support Neurovance, Inc: Consultant; Research Grant NLS Pharma: Consultant Noven: Consultant; Research Grant Otsuka America Pharmaceutical, Inc: Research Grant Pearson: Research Grant Pfizer: Consultant; Research Grant; Speaker's Bureau; Writing Support Purdue Pharma: Consultant; Research Grant Rhodes Pharmaceuticals: Consultant; Research Grant; Writing Support Shire: Consultant; Research Grant; Speaker's Bureau; Writing Support Sunovion Pharmaceuticals, Inc: Consultant; Research Grant; Writing Support Supernus Pharmaceuticals, Inc: Consultant; Research Grant Tris Pharma: Consultant; Research Grant; Speaker's Bureau; Writing Support

I do not intend to discuss

Page 26: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Chirla, Devicharan Senior Author, Co-Author

No None I do intend to discuss

Cho, Robert Co-Author, Senior Author

Yes DePuy Synthes: Consultant; Advisory Board Ergobaby Inc: Advisory Board NuVasive: Consultant

I do not intend to discuss

Christian, Cindy Co-Author Yes Government/Law Firms: Expert Testimony I do not intend to discuss

Christian, Cindy Abstract Reviewer

Yes Government/Law firms: Medical Legal Expert Work I do not intend to discuss

Clark, Nicholas Abstract Reviewer

Yes Novartis AG: Stocks/Bonds I do not intend to discuss

Comfort, Ryan Co-Author Yes Coffective, LLC: Employee I do not intend to discuss

Crespo, Eileen Co-Author, Senior Author

Yes Stratacor: Employee I do intend to discuss

Cronyn, Drew Abstract Reviewer

No None I do intend to discuss

Cruz, Jr., Aristides Co-Author, Presenting Author, Senior Author

Yes Journal of Bone & Joint Surgery: Question Writer I do not intend to discuss

Dahl, Benny Presenting Author, Senior Author

Yes K2M: Consultant I do not intend to discuss

Page 27: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Dampier, Carlton Co-Author Yes Epizyme: Consultant Hilton Publishing Company: Consultant Ironwood Pharmaceuticals: Consultant Merck: Consultant Micelle BioPharma: Consultant; Research Grant Modus Therapeutics: Consultant Novartis: Consultant; Research Grant Pfizer: Consultant; Research Grant

I do intend to discuss

Darbari, Deepika Co-Author, Senior Author

Yes Global Blood Therapeutics: Advisory Board Hilton Publishing Inc: Consultant Novartis: Committee Member

I do not intend to discuss

Davids, Jon Senior Author, Co-Author

Yes Orthopediatrics: Consultant I do not intend to discuss

Davidson, Kathryn Co-Author Yes Boston Children's Hospital: Employee I do not intend to discuss

DeCory, Heleen Senior Author Yes Bausch Health US, LLC: Employee I do not intend to discuss

deMayo, Richelle Abstract Reviewer

Yes Connecticut Children's: Employee I do not intend to discuss

DeSousa, Norberto Co-Author, Presenting Author

Yes Ironshore Pharmaceuticals & Development, Inc: Employee

I do not intend to discuss

Deveza, Lorenzo Co-Author, Presenting Author

Yes Lento Medical Inc: Stocks/Bonds I do not intend to discuss

Dias, Patricia Co-Author, Presenting Author

No None I do intend to discuss

Page 28: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Dodge, Ann Co-Author Yes Johnson and Johnson: Stocks/Bonds Merck: Stocks/Bonds Pfizer: Stocks/Bonds

I do not intend to discuss

Dong, Min Senior Author, Co-Author

No None I do intend to discuss

Downs, Stephen Senior Author, Co-Author

Yes Digital Health Solutions, LLC: Stocks/Bonds I do not intend to discuss

Eckert, Laurent Co-Author Yes Sanofi: Employee; Stocks/Bonds I do not intend to discuss

Einstein, Andrew Co-Author Yes Canon Medical Systems: Research Grant GE Healthcare: Consultant Roche Medical Systems: Research Grant

I do not intend to discuss

Emans, John Co-Author Yes Synthes Spine: Royalties Zimmer Biomet Spine: Consultant

I do not intend to discuss

Ernst, Kimberly Abstract Reviewer

Yes Baxter Healthcare: Consultant Fresenius Kabi: Consultant; Research Grant Nutrinia: Research Grant

I do not intend to discuss

Fairchild, Karen Co-Author, Senior Author

No None I do intend to discuss

Fairchild, Sarah Co-Author Yes Bryn Pharma: Consultant I do not intend to discuss

Page 29: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Faraone, Stephen Co-Author Yes Akili Interactive Labs: Research Grant Arbor Pharmaceuticals, LLC: Research Grant Elsevier: Royalties Genomind: Research Grant Guilford Press: Royalties Ironshore Pharmaceuticals & Development, Inc: Research Grant Janssen Pharmaceuticals, Inc: Research Grant Otsuka America Pharmaceutical, Inc: Research Grant Oxford University Press: Royalties Shire: Research Grant Sunovion Pharmaceuticals, Inc: Research Grant Supernus Pharmaceuticals, Inc: Research Grant VAYA Pharma: Research Grant ADHD in Adults: Principal Investigator

I do not intend to discuss

Fettig, Lyle Co-Author Yes VitalTalk: Honoraria I do not intend to discuss

Figueroa, Janet Co-Author No None I do intend to discuss

Finn, Paul Co-Author No None I do intend to discuss

Fleegler, Eric Presenting Author, Co-Author

Yes North Shore Hospital: Honorarium Wolters Kluwer: Royalties Veta Health: Consultant

I do not intend to discuss

Fletcher, Nicholas Co-Author Yes Medtronic: Consultant Orthopaediatrics: Consultant Zimmer/Biomet: Speaker's Bureau

I do not intend to discuss

Flynn, John Senior Author Yes Wolters Kluwer Heath - Lippincott Williams & Wilkins: Consultant Zimmer Biomet: Consultant

I do not intend to discuss

Flynn, Joseph Abstract Reviewer

Yes Silvergate Pharmaceuticals: Consultant Ultragenyx, Inc: Data Safety Monitoring Board

I do not intend to discuss

Page 30: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Fogel, Mark Senior Author, Presenting Author

No None I do intend to discuss

Forbes, Michael Co-Author Yes AstraZeneca: Consultant I do not intend to discuss

Frese, Steven Presenting Author, Co-Author, Senior Author

Yes Evolve Biosystems: Employee I do not intend to discuss

Friscia, Diana Co-Author Yes Johnson & Johnson Consumer, Inc: Employee I do not intend to discuss

Gadkari, Abhijit Senior Author Yes Regeneron Pharmaceuticals, Inc: Employee; Stocks/Bonds

I do not intend to discuss

Gair, Anne Presenting Author, Co-Author

No None I do intend to discuss

Garcia-Rodenas, Clara Co-Author Yes Nestle: Employee I do not intend to discuss

Gellasch, Patricia Co-Author, Presenting Author

Yes PEDS Online: Consultant I do not intend to discuss

Glascoe, Frances Co-Author Yes PEDS Test: Author I do not intend to discuss

Glauser, Tracy Co-Author Yes GeneSight: Consultant I do not intend to discuss

Glotzbecker, Michael Co-Author Yes Depuy Synthes: Speaker's Bureau GSSG, CSSG, HSG: Research Support Medtronic: Speaker's Bureau Nuvasive: Consultant; Speaker's Bureau Orthobullets: Consultant; Stocks/Bonds Zimmer Biomet: Speaker's Bureau

I do not intend to discuss

Page 31: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Golombek, Sergio Abstract Reviewer

Yes Mallinckrodt: Speaker's Bureau I do not intend to discuss

Goodman, Steven Co-Author Yes Scioto Biosciences: Stocks/Bonds I do intend to discuss

GORMAN, Amanda Presenting Author

Yes Gorman and Associates: Stocks/Bonds; Sole Proprietor (LLC)

I do not intend to discuss

Govardhan, Sparsha Co-Author No None I do intend to discuss

Grant, Makenzie Presenting Author, Co-Author

Yes Pavlok: Materials Support I do intend to discuss

Green, Daniel Co-Author, Senior Author

Yes American Academy of Orthopaedic Surgery: Board/Committee Member Arthrex, Inc: Consultant; Royalties Current Opinion in Pediatrics: Editorial or Governing board; Royalties; Financial or Material support New York County Medical Society: Board/Committee Member New York State Society of Orthopedic Surgeons: Board/Committee Member Pediatric Orthopaedic Society of North America: Board/Committee Member Pega Medical: Royalties Wolters Kluwer Health - Lippincott Williams & Wilkins: Royalties; Financial or Material support

I do not intend to discuss

Greenwald, Michael Co-Author No None I do intend to discuss

Gressett Hall, Monica Co-Author No None I do intend to discuss

Grundmeier, Bob Abstract Reviewer

Yes Care Assistant: Co-Inventor I do not intend to discuss

Page 32: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Gubanich, Paul Senior Author, Co-Author

Yes AMSSM: Honorarium Novo Nordisk: Research Grant O'Brien & Ryan, LLP: Consultant

I do not intend to discuss

Gupta, Purnendu Co-Author Yes Depuy, A Johnson & Johnson Company: Consultant I do not intend to discuss

Gura, Kathleen Co-Author Yes B Braun: Consultant Baxter: Consultant Fresenius Kabi: Consultant Northsea Therapeutics: Consultant Otsuka Pharmaceutical Company: Consultant

I do not intend to discuss

Gutman, Colleen Co-Author, Presenting Author

No None I do intend to discuss

Page 33: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Guttman-Yassky, Emma Senior Author, Co-Author

Yes Abbvie: Consultant; Research Grant; Investigator Anacor: Consultant Asana Biosciences: Consultant Celgene: Consultant; Research Grant; Investigator Daiichi Sankyo: Consultant DBV: Consultant Dermira: Consultant; Research Grant Eli Lilly: Consultant; Investigator Galderma: Consultant; Research Grant; Investigator GlaxoSmithKline: Consultant; Investigator Glenmark: Consultant; Investigator Innovaderm: Research Grant Janssen: Research Grant Kiniksa: Consultant Kyowa: Consultant LEO Pharma: Consultant; Research Grant; Investigator Menlo Therapeutics: Consultant Novartis: Consultant Pfizer: Consultant; Research Grant; Investigator Realm: Consultant Regeneron Pharmaceuticals, Inc: Consultant; Research Grant; Investigator Sanofi: Consultant; Research Grant; Investigator

I do not intend to discuss

Guzzetta, Nina Co-Author No None I do intend to discuss

Hageman, Joseph Abstract Reviewer

Yes Owlet, Inc: Consultant I do not intend to discuss

Hair, Amy Senior Author Yes Fresenius Kabi: Research Grant Prolacta Bioscience: Research Grant

I do not intend to discuss

Halpern-Felsher, Bonnie Co-Author Yes Tobacco Prevention Toolkit:Founder and Executive Director

I do not intend to discuss

Page 34: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Hannon, Tamara Co-Author, Senior Author

Yes Eli Lilly: Consultant I do not intend to discuss

Hannon, Tamara Abstract Reviewer

Yes Eli LIlly, Inc: Consultant I do not intend to discuss

Hardatt, Dianna Presenting Author

No None I do intend to discuss

Hardesty, Christina Co-Author Yes Medtronic, Inc: Consultant Orthopediatrics: Consultant

I do not intend to discuss

Hardin, Caitlin Presenting Author

Yes IQVIA: Employee I do not intend to discuss

Harrington, Kathy Co-Author, Senior Author

No None I do intend to discuss

Harris, Matthew Co-Author No None I do intend to discuss

Hassink, Sandra Co-Author, Presenting Author

Yes Weight Watchers: Advisory Committee (Former) I do intend to discuss

Hassink, Sandra Abstract Reviewer

Yes Weight Watchers: Adolescent Cmt. Member (Former)

I do not intend to discuss

Havena-Lastarria, Daniela

Presenting Author, Co-Author

No None I do intend to discuss

Hebert, Janene Co-Author Yes Coffective, LLC: Employee I do not intend to discuss

Heffron, Melinda Co-Author No None I do intend to discuss

Heiderich, Amy Presenting Author

Yes Johnson and Johnson: Employee I do not intend to discuss

Page 35: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Henrick, Bethany Co-Author, Presenting Author

Yes Evolve Biosystems: Employee I do not intend to discuss

Hirshon, Jon Mark Presenting Author, Co-Author

Yes Pfizer, Inc: Consultant I do not intend to discuss

Page 36: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Hong, Chih-ho Presenting Author, Co-Author

Yes Abbvie: Consultant; Research Grant; Speaker's Bureau; Speaker; Investigator; Consultant Amgen: Consultant; Research Grant; Speaker's Bureau; Speaker; Investigator; Consultant Bausch Health: Consultant; Speaker's Bureau Boehringer-Ingelheim: Consultant; Research Grant; Investigator Celgene: Consultant; Research Grant; Speaker's Bureau; Speaker; Investigator; Consultant Centocor: Research Grant; Investigator Cipher: Speaker's Bureau Cutanea: Research Grant; Investigator Dermavant: Research Grant; Investigator Eli Lilly: Consultant; Research Grant; Speaker's Bureau; Speaker; Investigator; Consultant Galderma: Consultant; Research Grant; Speaker's Bureau; Speaker; Investigator; Consultant GlaxoSmithKline: Research Grant; Investigator Janssen: Consultant; Research Grant; Speaker's Bureau; Speaker; Investigator; Consultant LEO Pharma: Consultant; Research Grant; Speaker's Bureau; Speaker; Investigator; Consultant MedImmune: Research Grant; Investigator Novartis: Consultant; Research Grant; Speaker's Bureau; Speaker; Investigator; Consultant Regeneron Pharmaceuticals, Inc: Consultant; Research Grant; Speaker's Bureau; Speaker; Investigator; Consultant Roche: Consultant; Speaker's Bureau Sanofi Aventis: Consultant

I do not intend to discuss

Hsu, Daphne Abstract Reviewer

Yes Bayer: Consultant Novartis: Consultant Rocket Pharmaceuticals: Consultant

I do not intend to discuss

Page 37: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Hu, Peng Co-Author No None I do intend to discuss

Hubbard, Dena Abstract Reviewer

Yes Abbott Nutrition: Speaker's Bureau I do not intend to discuss

Hunt, Elizabeth Co-Author, Senior Author

Yes Zoll Medical Corporation: Consultant I do not intend to discuss

Hunter, Krystal Co-Author No None I do intend to discuss

Iacobas, Ionela Co-Author No None I do intend to discuss

Incledon, Bev Co-Author, Presenting Author, Senior Author

Yes Ironshore Pharmaceuticals & Development, Inc: Employee

I do not intend to discuss

Indu, pathak Abstract Reviewer

No None I do intend to discuss

Izatt, Susan Presenting Author, Co-Author

Yes Carl Zeiss Meditech: Royalties Leica Microsystems, Inc: Royalties

I do not intend to discuss

Izuka, Byron Presenting Author

Yes Bloxr: Royalties Hely & Weber: Royalties

I do not intend to discuss

Jacobowski, Natalie Co-Author, Senior Author

No None I do intend to discuss

Jacobs, Cale Co-Author No None I do not intend to discuss

Jacobson, Elli Presenting Author

No None I do intend to discuss

Jahnke, Marla Co-Author, Senior Author

Yes Epidermolysis Bullosa Research Partners: Research Grant

I do not intend to discuss

Janow, Ginger Co-Author No None I do intend to discuss

Page 38: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Japp, Seda Co-Author, Senior Author

Yes Bryn Pharma: Consultant I do not intend to discuss

Javidan, Yashar Co-Author No None I do intend to discuss

Jenkins, Kathy Co-Author Yes NuMed: Research Grant I do not intend to discuss

Jenkins, Kathy Senior Author Yes NuMed: Research Grant I do not intend to discuss

Johnson, Jessica Co-Author Yes Yakima Valley Farm Workers Clinic: Employee I do not intend to discuss

Johnstone, Sarah Co-Author, Senior Author

Yes Bryn Pharma: Consultant I do not intend to discuss

Jois, Sukruthi Co-Author No None I do intend to discuss

Kaelber, David Abstract Reviewer

Yes CareSource of Ohio: Board of Directors (former) I do not intend to discuss

Kaplan, Karen Abstract Reviewer

Yes Merck: Employee; Stocks/Bonds I do not intend to discuss

Karav, Sercan Co-Author Yes Evolve Biosystems: Consultant; Research Grant I do not intend to discuss

Karpen, Heidi Co-Author Yes Prolacta Bioscience: Research Grant I do not intend to discuss

Kay, Robert Co-Author, Senior Author

Yes Biomet: Stocks/Bonds Commission for Motion Lab Accreditation: Board/Committee Member Johnson & Johnson: Stocks/Bonds Journal of Pediatric Orthopaedics: Editorial or Governing board Medtronic: Stocks/Bonds Pfizer: Stocks/Bonds Zimmer: Stocks/Bonds

I do not intend to discuss

Page 39: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Kazi, Sufyan Senior Author, Co-Author

Yes Evolve Biosystems: Employee I do not intend to discuss

Kelly, Joseph Co-Author, Presenting Author

Yes CAT Resources: Materials Support I do not intend to discuss

Kelly, Matthew Presenting Author, Co-Author

No None I do intend to discuss

Kilpatrick, Ryan Presenting Author, Co-Author

No None I do intend to discuss

Kim, Esther Presenting Author

No None I do intend to discuss

Kim, Jae Co-Author Yes Abbott Nutrition: Speaker's Bureau Alcresta: Consultant Astarte: Stocks/Bonds Ferring: Consultant Mallinckrodt: Research Grant Mead Johnson Nutrition: Speaker's Bureau Medela: Consultant Nicolette: Stocks/Bonds

I do not intend to discuss

Kinsella, Sarah Abstract Reviewer

Yes Optum: Employee I do not intend to discuss

Kirkendall, Eric Abstract Reviewer

Yes Vigilanxz: Royalties I do not intend to discuss

Klein, Bruce Co-Author, Senior Author

Yes Johnson & Johnson: Stocks/Bonds I do not intend to discuss

Page 40: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Klineberg, Eric Co-Author, Senior Author

Yes AOSpine: Speaker's Bureau; Fellowship Grant Depuy Synthes: Consultant K2M: Speaker's Bureau Medicrea: Consultant Stryker: Consultant

I do not intend to discuss

Knadler, Joseph Co-Author, Presenting Author

No None I do intend to discuss

Kobayashi, Ai Lan Co-Author, Senior Author

No None I do intend to discuss

Kobayashi, Roger Senior Author No None I do intend to discuss

Kramer, Dennis Abstract Reviewer

Yes Kairos Surgical: Educational support I do not intend to discuss

Kumar, Anand Senior Author, Co-Author

Yes Depuy Synthes: Consultant KLS Martin: Research Grant Polarity TE: Consultant

I do not intend to discuss

Kumari, Polly Co-Author No None I do intend to discuss

Kuo, Dennis Co-Author Yes MAXX Orthopedics: Consultant I do not intend to discuss

Labreze, Christine Presenting Author, Co-Author

Yes Pierre Fabre: Consultant I do not intend to discuss

Lawrence, J. Todd Co-Author, Senior Author

Yes Sawbones Inc: Stocks/Bonds I do not intend to discuss

Lawrence, J. Todd Abstract Reviewer

Yes Sawbones: Royalties I do not intend to discuss

Lee, Cami Co-Author No None I do intend to discuss

Page 41: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Lee, Lois Presenting Author, Senior Author

Yes Wolters Kluwer: Royalties I do not intend to discuss

Lee, Lois Abstract Reviewer

Yes Wolters Kluwer: Author I do not intend to discuss

Lefkowitch, Jay Co-Author No None I do intend to discuss

Legge, Donna Co-Author No None I do intend to discuss

Lenke, Lawrence Co-Author Yes Broadwater: Travel Reimbursement AOSpine: Travel Reimbursement; Grant Support; Fellowship; Research Grant EOS: Grant Support; Research Grant Medtronic: Paid Consultant; Royalties; Consultant Quality Medical Publishing: Royalties Scoliosis Research Society: Travel Reimbursement; Grant Support Setting Scoliosis Straight Foundation: Grant Support; Research Grant

I do not intend to discuss

Levy, Matthew Co-Author Yes Stop the Bleeding Coalition: Chair I do not intend to discuss

Li, Su-Ting Co-Author, Senior Author

Yes Amgen: Stocks/Bonds Eli Lily: Stocks/Bonds Johnson and Johnson: Stocks/Bonds Merck: Stocks/Bonds Procter and Gamble: Stocks/Bonds

I do not intend to discuss

Lim, Foong Yeng Co-Author, Senior Author

No None I do intend to discuss

Linden, Allison Co-Author No None I do intend to discuss

Linkenbach, Jeff Co-Author Yes The Montana Institute: Stocks/Bonds I do not intend to discuss

Page 42: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Liu, Raymond Abstract Reviewer

Yes Orthopediatrics: Royalties I do not intend to discuss

Long, Melissa Co-Author, Presenting Author

Yes Masimo: Stocks/Bonds I do not intend to discuss

Lorenzo, Matthew Presenting Author, Co-Author

No None I do intend to discuss

Lossius, Michelle Co-Author Yes Biomarin: Research Grant I do not intend to discuss

Luhmann, Scott Co-Author, Senior Author

Yes Globus: Royalties Medtronic: Consultant; Speaker's Bureau; Royalties Orthopaediatrics: Consultant; Speaker's Bureau Stryker Spine: Consultant; Speaker's Bureau; Royalties Wishbone Medical: Consultant Wolters Kluwer: Royalties

I do not intend to discuss

Mackenzie, W.G. Stuart Co-Author Yes Stryker: Employee (Brother) I do not intend to discuss

Mackenzie, William Senior Author Yes Stryker: Employee (Son) I do not intend to discuss

Madden, Jessica Co-Author, Presenting Author

Yes Primrose Newborn Care, LLC: Owner and Founder I do not intend to discuss

Maradiaga Panayotti, Gabriela

Presenting Author, Co-Author

Yes Carolina Global Breastfeeding Institute: Speaker's Bureau

I do not intend to discuss

Marahatta, Anu Co-Author No None I do intend to discuss

Mayer, Stephanie Co-Author, Presenting Author

Yes Arthrex: Consultant Stryker: Consultant

I do not intend to discuss

Page 43: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Mazzetti, Alessendro Presenting Author, Senior Author

Yes Cassiopea SpA: Employee; Stocks/Bonds Cosmo Pharmaceuticals: Consultant; Stocks/Bonds

I do intend to discuss

McCormick, Meghan Abstract Reviewer

No None I do intend to discuss

McElhinney, Kathryn Presenting Author, Co-Author

No None I do intend to discuss

McLoughlin, Robert Co-Author Yes Sunovion Pharmaceuticals: Employee I do not intend to discuss

Meaney-Delman, Dana Co-Author No None I do intend to discuss

Meier, Paula Co-Author Yes Medela, Inc: Research Grant I do not intend to discuss

Meisel, Erin Co-Author Yes Joint Development LLC: Stocks/Bonds I do not intend to discuss

Melamed, Isaac Presenting Author

Yes Octapharma: Research Grant I do intend to discuss

Meyer, Keith Abstract Reviewer

Yes DoctorFare, Inc: Stocks/Bonds McGraw Hill, Inc: Royalties

I do not intend to discuss

Meyer, Rina Co-Author No None I do intend to discuss

Michel, Jeremy Presenting Author

Yes American Academy of Pediatrics: Consultant Children's Hospital of Philadelphia: Employee ECRI Institute: Consultant

I do not intend to discuss

Millis, Michael Presenting Author, Co-Author

Yes Saunders/Mosby-Elsevier: Royalties; Financial or Material Support

I do not intend to discuss

Mina-Osorio, Paola Presenting Author, Co-Author

Yes Regeneron Pharmaceuticals, Inc: Employee; Stocks/Bonds

I do not intend to discuss

Page 44: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Miranda, Holly Co-Author No None I do intend to discuss

Mistovich, R Justin Co-Author, Senior Author

Yes OrthoPediatrics: Consultant Right Mechanics: Stocks/Bonds

I do not intend to discuss

Mitchell, Ryan Co-Author Yes Evolve Biosystems Inc: Employee I do not intend to discuss

Mohamed, Ashraf Abstract Reviewer

Yes Novartis: Speaker's Bureau I do not intend to discuss

Montalbano, Amanda Co-Author, Senior Author

Yes Urgent Care Association: Speaker's Bureau I do not intend to discuss

Moorman, J. Randall Co-Author Yes AMP3D: Stocks/Bonds I do not intend to discuss

Moorthy, Ganga Presenting Author

No None I do intend to discuss

Moro, Luigi Co-Author Yes Cassiopea SpA: Employee; Stocks/Bonds Cosmo Pharmaceuticals: Employee; Stocks/Bonds

I do intend to discuss

Morris, Claudia Presenting Author, Senior Author

Yes Pfizer: Consultant PharmaNutrients, Inc: Royalties

I do not intend to discuss

Morris, Claudia Abstract Reviewer

Yes LifeTrients: Royalties Pfizer: Consultant

I do not intend to discuss

Mowitz, Meredith Abstract Reviewer

Yes Takeda-Shire: Consultant I do not intend to discuss

Myers, John Presenting Author, Co-Author

No None I do intend to discuss

Nandyal, Raja Abstract Reviewer

No None I do intend to discuss

Page 45: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Nandyal, Rajagopal Abstract Reviewer

No None I do intend to discuss

Natividad, Jane Mea M Presenting Author

Yes Nestle: Employee I do not intend to discuss

Needelman, Howard Co-Author, Presenting Author

No None I do intend to discuss

Needelman, Howard Abstract Reviewer

Yes Springer Publication: Editor; Royalties I do not intend to discuss

Newcorn, Jeffrey Co-Author, Senior Author

Yes Akili Interactive Labs: Consultant Cingulate Therapeutics: Consultant Enzymotec: Consultant; Research Grant NeuroLifeSciences Pharma: Consultant Otsuka America Pharmaceutical, Inc: Research Grant Pfizer: DSMB member Rhodes Pharmaceuticals: Consultant Shire: Consultant; Research Grant; Meeting honorarium Sunovion Pharmaceuticals, Inc: DSMB member Supernus Pharmaceuticals, Inc: Consultant; Research Grant U.S. National Football League: Consultant

I do not intend to discuss

Newland, Jason Co-Author Yes Allergan: Clinical trial Merck: Research Grant

I do not intend to discuss

Nguyen, Kim-Lien Co-Author No None I do intend to discuss

Nikolovski, Janeta Co-Author, Senior Author

Yes Johnson & Johnson Consumer, Inc: Employee I do not intend to discuss

Nolan, Heather Co-Author No None I do intend to discuss

Page 46: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

O'Connor, Maeve Co-Author No None I do intend to discuss

Okonkwo, Ikechukwu Senior Author, Co-Author

No None I do intend to discuss

Olivieri, Laura Co-Author, Senior Author

No None I do intend to discuss

Olson, Andrew Presenting Author, Co-Author

No None I do intend to discuss

Olutoye, Oluyinka Abstract Reviewer

Yes Cambridge Publishers: Royalty Covidien: Research Grant Mallinckrodt: Research Grant Up-To-Date: Royalty

I do not intend to discuss

Pace, J. Lee Co-Author, Senior Author

Yes American Orthopaedic Society for Sports Medicine: Board/Committee Member Arthrex, Inc: Consultant Ceterix, Inc: Consultant Grand Rounds, Inc: Consultant Pediatric Orthopaedic Society of North America: Board/Committee Member Pediatric Research in Sports Medicine: Board/Committee Member

I do not intend to discuss

Pahys, Joshua Co-Author Yes DePuy Synthes: Consultant NuVasive: Consultant Zimmer Biomet: Consultant

I do not intend to discuss

Page 47: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Paller, Amy S. Co-Author, Presenting Author

Yes Abbvie: Consultant; Research Grant Amgen: Consultant AnaptysBio: Research Grant; Investigator Asana: Consultant Dermavant: Consultant Dermira: Consultant Eli Lilly: Consultant; Research Grant; Investigator Forte: Consultant Galderma: Consultant; Research Grant; Investigator Incyte: Research Grant; Investigator Janssen: Research Grant; Investigator LEO Pharma: Consultant; Research Grant; Investigator Matrisys Bioscience: Consultant Menlo Therapeutics: Consultant MorphoSys/Galapagos: Consultant Novartis: Consultant; Research Grant; Investigator Pfizer: Consultant Regeneron Pharmaceuticals, Inc: Consultant; Research Grant; Investigator Sanofi: Consultant; Research Grant; Investigator

I do not intend to discuss

Papillon, Stephanie Co-Author, Presenting Author

No None I do intend to discuss

Parker, Margaret Abstract Reviewer

No None I do intend to discuss

Partington, Sara Presenting Author, Co-Author

No None I do intend to discuss

Patel, Aloka Co-Author Yes Mead Johnson Nutrition: Research Grant I do not intend to discuss

Page 48: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Perez, Jose Abstract Reviewer

Yes Mallinkrodt: Speaker's Bureau I do not intend to discuss

Pestian, John Co-Author Yes Clarigent: Consultant GeneSight: Consultant

I do not intend to discuss

Pliszka, Steven Senior Author, Co-Author

Yes AstraZeneca: Expert Witness Ironshore Pharmaceuticals & Development, Inc: Consultant; Research Grant

I do not intend to discuss

Pohl, Erin Co-Author Yes Bryn Pharma: Consultant I do not intend to discuss

Pollack, Ari Abstract Reviewer

Yes Apple: Stocks/Bonds I do not intend to discuss

Poon, Selina Senior Author, Co-Author, Presenting Author

Yes NuVasive: Research Grant I do not intend to discuss

Prasad, Rajeev Co-Author No None I do intend to discuss

Prescilla, Randy Co-Author Yes Sanofi Genzyme: Employee; Stocks/Bonds I do not intend to discuss

Pruitt, Chris Co-Author No None I do intend to discuss

Puder, Mark Presenting Author, Senior Author

Yes Fresenius Kabi: Consultant; Patent I do not intend to discuss

Qudsi, Rameez Co-Author, Presenting Author

Yes OrthoBullets: Consultant I do not intend to discuss

Rafton, Sarah Co-Author No None I do intend to discuss

Rashid, Nazia Co-Author No None I do intend to discuss

Page 49: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Reber, Kristina Abstract Reviewer

Yes Children's Hospital Neonatal Consortium: Board Member

I do not intend to discuss

Ren, Yaya Presenting Author, Co-Author

Yes PreeMe+You: Stocks/Bonds I do not intend to discuss

Rhodes, Jason Co-Author Yes Gait and Clinical Movement Analysis Society: Board/Committee Member Orthopediatrics: Consultant Pediatric Orthopaedic Society of North America: Board/Committee Member Pediatric Research in Sports Medicine: Board/Committee Member

I do not intend to discuss

Riccio, Anthony Co-Author, Senior Author

Yes Arthrex: Research Grant Elsevier: Royalties

I do not intend to discuss

Riley, Carley Co-Author Yes Hugo: Employee Institute for Healthcare Improvement: Consultant

I do not intend to discuss

Rochford, Laura Co-Author, Presenting Author

Yes Pavlok: Materials Support I do intend to discuss

Roiz, Ronald Co-Author Yes Medtronic: Financial or Material Support I do not intend to discuss

Rossi, Ana B. Co-Author Yes Sanofi: Employee; Stocks/Bonds I do not intend to discuss

Rumler, Sarah Abstract Reviewer

Yes Dexcom, Inc: Stocks/Bonds Hill Rom Holdings: Stocks/Bonds Integer Holdings Corp: Stocks/Bonds Intersect ENT: Stocks/Bonds

I do not intend to discuss

Rybicki, Steven Co-Author Yes Bryn Pharma: Consultant I do not intend to discuss

Rytz, Andreas Co-Author Yes Nestle: Employee I do not intend to discuss

Page 50: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Sallee, Randy Co-Author Yes Ironshore Pharmaceuticals, Inc: Employee P2D Bioscience: Member; Board of Directors

I do not intend to discuss

Samdani, Amer Co-Author Yes DePuy Synthes Spine: Consultant Ethicon: Consultant Globus Medical: Consultant NuVasive: Consultant; Royalties Stryker: Consultant Zimmer Biomet: Consultant; Royalties

I do not intend to discuss

Sanders, James Co-Author Yes Abbott: Stocks/Bonds Abbvie: Stocks/Bonds GE Healthcare: Stocks/Bonds GreenSun: Financial or Material Support

I do not intend to discuss

Sanfilippo, Christine Co-Author Yes Bausch Health US, LLC: Employee I do not intend to discuss

Sarwahi, Vishal Co-Author, Presenting Author

Yes Depuy Synthes: Consultant Nuvasive: Consultant Precision Spine: Consultant

I do not intend to discuss

Sawyer, Jeffrey Co-Author Yes depuy: Consultant Elsevier: Royalties (Textbook) Orthopaediatrics: Consultant Republic Spine: Consultant

I do not intend to discuss

Schechterman, Andrew Co-Author No None I do intend to discuss

Scherl, Susan Abstract Reviewer

Yes Lippincott: Royalties Wolters Kluwer: Royalties

I do not intend to discuss

Scheurer, Johannah Co-Author No None I do intend to discuss

Schreck, Paula Co-Author, Presenting Author

Yes Coffective, LLC: Consultant I do intend to discuss

Page 51: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Sebsibie, Girum Presenting Author, Co-Author

No None I do intend to discuss

Sege, Robert Senior Author, Presenting Author

Yes The Montana Institute: Consultant I do not intend to discuss

Sekhar, Deepa Abstract Reviewer

Yes American Kidney Stone Management: Stocks/Bonds Higmark Foundation: Research Grant Pfizer: Research Grant

I do not intend to discuss

Shah, Nipam Co-Author Yes Pavlok: Company is providing our research study with the wearable wristbands and is also available for technical support if/when needed.

I do intend to discuss

Shah, Sona Co-Author Yes Neopenda: Employee; Stocks/Bonds I do not intend to discuss

Page 52: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Shah, Suken Co-Author Yes AAOS: Board/Committee Member DePuy Synthes Spine: Consultant; IP royalties DePuy Synthes Spine via Setting Scoliosis Straight Foundation: Research support Electrocore: Stocks/Bonds EOS Imaging: Consultant Globus Medical: Consultant Innovative Surgical Designs, Inc: Stocks/Bonds K2M: Stocks/Bonds; IP royalties K2M via Setting Scoliosis Straight Foundation: Research support NuVasive: Consultant NuVasive via Setting Scoliosis Straight Foundation: Research support Pediatric Orthopaedic Society of North America: Board/Committee Member Scoliosis Research Society: Board/Committee Member Setting Scoliosis Straight Foundation: Consultant; Board/Committee Member Springer: Publishing royalties; Financial or material support

I do not intend to discuss

Shames, Adam Presenting Author, Co-Author

Yes Bryn Pharma: Consultant I do not intend to discuss

Shiva, Sruti Co-Author No None I do intend to discuss

Page 53: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Siegfried, Elaine C. Presenting Author, Co-Author

Yes Dermavant: Consultant Eli Lilly: Consultant; Research Grant; Principal investigator in clinical trials GlaxoSmithKline: Data and Safety Monitoring Board Janssen: Research Grant; Principal investigator in clinical trials. LEO Pharma: Data and Safety Monitoring Board Novan: Data and Safety Monitoring Board Pfizer: Consultant Regeneron Pharmaceuticals, Inc: Consultant; Research Grant; Principal investigator in clinical trials Stiefel: Principal investigator in clinical trials. Verrica: Consultant; Research Grant; Principal investigator in clinical trials

I do not intend to discuss

Simpson, Eric L. Presenting Author, Co-Author

Yes Abbvie: Consultant; Research Grant Boehringer-Ingelheim: Consultant Dermavant: Consultant Eli Lilly: Consultant; Research Grant Forte Bio: Consultant Galderma: Research Grant Incyte: Consultant Kyowa Hakko Kirin: Research Grant LEO Pharma: Consultant; Research Grant Menlo Therapeutics: Consultant Merck: Research Grant Pfizer: Consultant; Research Grant Pierre Fabre Dermo Cosmetique: Consultant Regeneron Pharmaceuticals, Inc: Consultant; Research Grant Sanofi Genzyme: Consultant Valeant: Consultant

I do not intend to discuss

Page 54: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Skaggs, David Presenting Author, Co-Author, Senior Author

Yes Biomet Spine: Consultant; Royalties; Speaker Grand Rounds: Consultant Green Sun Medical: Stocks/Bonds Growing Spine Foundation: Board/Committee Member Growing Spine Study Group: Board/Committee Member Journal of Children's Orthopedics: Editorial or governing board Medtronic: Financial or Material Support NuVasive: Consultant; Co-PI (Paid to Growing Spine Foundation); Research Grant; Research support Orthobullets: Consultant; Stocks/Bonds; Editorial or governing board Orthopedics Today: Editorial or governing board Spine Deformity: Editorial or governing board Wolters Kluwer Health - Lippincott Williams & Wilkins: Publishing royalties; Financial or material support Zimmer: Financial or Material Support; Speaker; Consultant Zipline Medical, Inc: Stocks/Bonds

I do not intend to discuss

Slamon, Nicholas Senior Author Yes Eko: Consultant; Stocks/Bonds I do not intend to discuss

Page 55: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Smith, John Co-Author Yes Chest Wall and Spine Deformity Research Foundation: Board/Committee Member Children's Spine Foundation: Board of Directors DepuySynthes: Consultant Ellipse Technologies: Consultant Globus: Consultant; Royalties Missinox: Speaker's Bureau Nuvasive: Consultant Spineguard: Consultant Zimmer Biomet: Consultant

I do not intend to discuss

Soghier, Lamia Co-Author, Senior Author

Yes AAP: Royalties I do not intend to discuss

Song, Clara Abstract Reviewer

Yes Mead Johnson Nutrition: Speaker's Bureau I do not intend to discuss

Son-Hing, Jochen Co-Author Yes OrthoPediatrics: Consultant I do not intend to discuss

Soosaar, Jennifer Senior Author, Presenting Author

Yes Bryn Pharma: Consultant I do not intend to discuss

Sponseller, Paul Co-Author, Senior Author

Yes Globus: Royalties Johnson and Johnson: Research Grant; Royalties Orthopediatrics: Consultant

I do not intend to discuss

Stewart, Amanda Abstract Reviewer

Yes Boston Scientific Corporation: Employee I do not intend to discuss

Strain, Paul Presenting Author, Co-Author

No None I do intend to discuss

Page 56: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Study Group, Children's Spine

Co-Author Yes DePuy, A Johnson & Johnson Company: Research Grant NuVasive, Inc: Research Grant

I do not intend to discuss

Study Group, Growing Spine

Co-Author Yes Food and Drug Administration: Research Grant Growing Spine Foundation: Research Grant Nuvasive: Research Grant Pediatric Orthopedic Society of North America: Research Grant

I do not intend to discuss

Swanson, Jonathan Abstract Reviewer

Yes Prolacta Bioscience, Inc: Speaker's Honorarium; Travel Reimbursement

I do not intend to discuss

Sylvester, Karl Abstract Reviewer

Yes Avexegen: Consultant; Stocks/Bonds Evolve Therapeutics: Consultant HBI Solutions: Stocks/Bonds Sera Care: Research Grant

I do not intend to discuss

Telofski, Lorena Presenting Author, Co-Author

Yes Johnson & Johnson Consumer, Inc: Employee I do not intend to discuss

Thompson, George Co-Author Yes Broadwater, Inc: Consultant NuVasive: Travel Expenses OrthoPediatrics: Consultant; Stocks/Bonds Shriner's Hospital for Children: Travel Expenses, Medical Advisory Board Wolters Kluwer: Employee; Editor

I do not intend to discuss

Tolo, Vernon Presenting Author, Co-Author

Yes Journal of Bone and Joint Surgery - American: Royalties; Financial or Material Support Wolters Kluwer Health - Lippincott Williams & Wilkins: Royalties; Financial or Material Support

I do not intend to discuss

Page 57: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Trent, Maria Senior Author Yes Church & Dwight: Consultant Hologic, Inc: Research Grant SpeeDx: Research Supplies

I do not intend to discuss

Truong, Uyen Co-Author No None I do intend to discuss

Turer, Christy Senior Author, Co-Author

Yes Health@Hand LLC: Stocks/Bonds I do not intend to discuss

Vinks, Alexander Co-Author No None I do intend to discuss

Vitale, Michael Co-Author, Senior Author

Yes Biomet: Consultant Childrens Spine Foundation: Board/Committee Member; Research support ECOP: IP royalties IPOS: Board/Committee Member NuVasive: Consultant OREF: Research support Pediatric Orthopaedic Society of North America: Board/Committee member Project for Safety in Spine Surgery: Board/Committee Member Stryker: Consultant

I do not intend to discuss

Von Bergen, Nicholas Co-Author Yes Atrility Medical: Stocks/Bonds I do not intend to discuss

Wang, Yinna Presenting Author, Co-Author

No None I do intend to discuss

Ware, Julie Co-Author, Senior Author

No None I do intend to discuss

Ware, russell Presenting Author

No None I do intend to discuss

Page 58: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Watt, Amanda Co-Author No None I do intend to discuss

Weibel, Lisa Co-Author Yes Pierre Fabre: Consultant I do not intend to discuss

Welborn, Michelle Co-Author Yes Depuy Synthes: Consultant Pediatric Orthopedic Society of North America: Research Grant Shriners Hospital for Children: Employee; Research Grant

I do not intend to discuss

Whitehead, Kevin Co-Author, Senior Author

No None I do intend to discuss

Whitfill, Travis Co-Author Yes 410 Medical Inc: Board member I do not intend to discuss

Wilens, Timothy Presenting Author, Co-Author

Yes Alcobra Pharma: Consultant Cambridge Press: Co-Editor Elsevier: Co-Editor; Consultant Guilford Press: Editor Ironshore Pharmaceuticals & Development, Inc: Consultant; Licensing Agreement KemPharm, Inc: Consultant National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA): Consultant; Research Grant Neurovance, Inc: Consultant Otsuka America Pharmaceutical, Inc: Consultant Sunovion Pharmaceuticals, Inc: Consultant U.S. Minor/Major League Baseball: Consultant U.S. National Football League (ERM Associates): Consultant

I do not intend to discuss

Wilfley, Denise E Presenting Author, Co-Author

Yes Shire Pharmaceuticals: Consultant Sunovion Pharmaceuticals: Consultant Weight Watchers: Consultant

I do not intend to discuss

Page 59: Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name Role Relevant Financial

Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)* Please list name(s) of entity

AND Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds

excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they

plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an

unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Revised March 2018

Williams, Conrad Co-Author, Senior Author

Yes RMS products: Consultant I do not intend to discuss

Willimon, S. Clifton Co-Author Yes Smith & Nephew Endoscopy: Consultant I do not intend to discuss

Wolfe, Heather Senior Author Yes Zoll Medical: Speaker's Bureau I do not intend to discuss

Yen, Yi-Meng Abstract Reviewer

Yes Orthopediatrics: Consultant Smith-Nephew: Consultant

I do not intend to discuss

Zebrick, Ava J. Presenting Author, Co-Author

Yes Novo Nordisk: Consultant; Speaker's Bureau I do not intend to discuss

Zertuche, Pablo Co-Author, Presenting Author

No None I do intend to discuss

Zmitrovich, April Co-Author No None I do intend to discuss